Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation
Open Access
- 5 October 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 58 (5) , 1036-1043
- https://doi.org/10.1093/jac/dkl386
Abstract
Objectives: Determining the relationship between antiretroviral adherence and resistance accumulation is important for the design and evaluation of adherence interventions. Our objective was to explain heterogeneity observed in this relationship. Methods: We first conducted a systematic review to locate published reports describing the relationship between adherence and resistance. We then used a validated computer simulation to simulate the patient populations in these reports, exploring the impact of changes in individual patient characteristics (age, CD4, viral load, prior antiretroviral experience) on the shape of the adherence–resistance (A–R) curve. Results: The search identified 493 titles, of which 3 contained relevant primary data and 2 had sufficient follow-up for inclusion (HOMER and REACH cohorts). When simulating HOMER, the A–R curve had a high peak with a greatly increased hazard ratio (HR) of accumulating mutations at partial compared to complete adherence (simulation, HR 2.9; HOMER, HR 2.7). When simulating REACH, the A–R curve had a shallow peak with a slightly increased hazard of accumulating mutations at partial adherence (simulation, HR 1.2; REACH, HR 1.4). This heterogeneity was primarily attributable to differences in antiretroviral experience between the cohorts. Conclusions: Our computer simulation was able to explain much of the heterogeneity in observed A–R curves.Keywords
This publication has 19 references indexed in Scilit:
- Estimating the proportion of patients infected with HIV who will die of comorbid diseasesThe American Journal of Medicine, 2005
- Predictors of HIV Drug‐Resistance Mutations in a Large Antiretroviral‐Naive Cohort Initiating Triple Antiretroviral TherapyThe Journal of Infectious Diseases, 2005
- Modeling the HIV Protease Inhibitor Adherence–Resistance Curve by Use of Empirically Derived EstimatesThe Journal of Infectious Diseases, 2004
- High levels of adherence do not prevent accumulation of HIV drug resistance mutationsAIDS, 2003
- Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patientsAIDS, 2001
- HIV in the United States at the turn of the century: an epidemic in transitionAmerican Journal of Public Health, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Incidence and Predictors of Virologic Failure of Antiretroviral Triple-Drug Therapy in a Community-Based CohortAIDS Research and Human Retroviruses, 1999
- Validation of Patient Reports, Automated Pharmacy Records, and Pill Counts With Electronic Monitoring of Adherence to Antihypertensive TherapyMedical Care, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998